ArticleScience (New York, N.Y.)2010
Medicine. Prion-like behavior of amyloid-beta.
Article in Science (New York, N.Y.), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Diverse Misfolded Conformational Strains and Cross-seeding of Misfolded Proteins Implicated in Neurodegenerative Diseases.Frontiers in molecular neuroscience · 2019Article
- An intranasally delivered peptide drug ameliorates cognitive decline in Alzheimer transgenic mice.EMBO molecular medicine · 2017Article
- The real-time quaking-induced conversion assay for detection of human prion disease and study of other protein misfolding diseases.Nature protocols · 2016Article
- Pre-amyloid oligomers budding:a metastatic mechanism of proteotoxicity.Scientific reports · 2016Article
- Stem and Progenitor Cell-Based Therapy of the Central Nervous System: Hopes, Hype, and Wishful Thinking.Cell stem cell · 2016Review
- β-hairpin-mediated formation of structurally distinct multimers of neurotoxic prion peptides.PloS one · 2014Article
- Is AD a homogeneous nosologic entity? Yes.Journal of neural transmission (Vienna, Austria : 1996) · 2013Article
- Alzheimer's disease and prion protein.Intractable & rare diseases research · 2013Review
- Genetics of dementia.Seminars in neurology · 2011Review
- Amelogenin "nanorods" formation during proteolysis by Mmp-20.Journal of structural biology · 2011Article
- Review
- Review
- Article
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
21071652What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.